Migraine and Homoeopathy: An Integrative Review

Background: Migraine is one of the most common neurological disorders and is a major cause of disability worldwide. Despite the availability of effective conventional therapies, many patients continue to experience recurrent attacks, inadequate symptom relief, or treatment-related adverse effects. Consequently, there is increasing interest in complementary and integrative approaches, including homoeopathy.
Objective: The present review aimed to provide an integrated overview of migraine and to evaluate the available evidence regarding the role of individualized homoeopathic treatment in its management.
Methodology: A structured literature review was conducted using electronic databases including PubMed/MEDLINE, Scopus, Google Scholar, ScienceDirect, Cochrane Library, and Web of Science. Additional information was obtained from the World Health Organization (WHO), Global Burden of Disease (GBD) studies, and the International Classification of Headache Disorders, Third Edition (ICHD-3). Peer-reviewed articles published between 2019 and 2026 were reviewed, while landmark classification papers and earlier key studies on homoeopathy were included where relevant. Published clinical studies, systematic reviews, and case reports were critically analyzed.
Result: The reviewed literature indicates that evidence supporting homoeopathy in migraine management remains limited and inconsistent. Systematic reviews and randomized controlled trials have reported mixed findings, highlighting the need for further high-quality research.
Conclusion: Individualized homoeopathic treatment may provide symptomatic improvement in selected patients with migraine when used as part of an integrative management approach. However, the current scientific evidence is insufficient to establish definitive efficacy.

Homoeopathy, Migraine, Headache, Integrative Medicine

1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi:10.1177/0333102417738202. [Google Scholar] [Crossref]

2. GBD 2021 Diseases and Injuries Collaborators. Global burden of 288 causes of death and disability, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2100-2132. [Google Scholar] [Crossref]

3. Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, burden, and comorbidity. Neurol Clin. 2019;37(4):631-649. doi:10.1016/j.ncl.2019.06.001. [Google Scholar] [Crossref]

4. Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z. Migraine remains second among the world's causes of disability, and first among young women: findings from the Global Burden of Disease Study 2019. J Headache Pain. 2020;21(1):137. doi:10.1186/s10194-020-01208-0. [Google Scholar] [Crossref]

5. Ashina M. Migraine. New England Journal of Medicine. 2020;383:1866–1876. doi:10.1056/NEJMra1915327. [Google Scholar] [Crossref]

6. Ferrari MD, Goadsby PJ, Burstein R, et al. Migraine. Nature Reviews Disease Primers. 2022;8:2. doi:10.1038/s41572-021-00328-4. [Google Scholar] [Crossref]

7. Olesen J. International Classification of Headache Disorders (ICHD-3): Clinical applications. Cephalalgia. 2018;38(1):1–211. [Google Scholar] [Crossref]

8. Ailani J, Burch RC, Robbins MS. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021–1039. [Google Scholar] [Crossref]

9. Mathie RT, et al. Systematic reviews of randomized controlled trials of individualized homoeopathic treatment. Systematic Reviews. 2023. [Google Scholar] [Crossref]

10. Stub T, Musial F, Kristoffersen AE, et al. Complementary and integrative medicine in migraine: Current evidence and future perspectives. Frontiers in Neurology. 2024. [Google Scholar] [Crossref]

11. Modi S, Lowder DM. Migraine headache: diagnosis and treatment. Am Fam Physician. 2015 Aug 15;92(4):271-280. PMID: 26273080. PMCID: PMC4541429. [Google Scholar] [Crossref]

12. National Institute for Health and Care Excellence (NICE). Headaches in over 12s: diagnosis and management. NICE guideline NG150. London: NICE; updated 2021. [Google Scholar] [Crossref]

13. Dodick DW. Migraine. Lancet. 2018;391(10127):1315-30. [Google Scholar] [Crossref]

14. Burch R. Antiseizure drugs for migraine prevention. Continuum (Minneap Minn). 2018;24(4):1052-65. [Google Scholar] [Crossref]

15. American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59(1):1-18. [Google Scholar] [Crossref]

16. Sarkar BK. Organon of Medicine by Samuel Hahnemann: with an introduction and commentary on the text. 9th rev ed. Delhi: Birla Publications Pvt. Ltd.; 2004. [Google Scholar] [Crossref]

17. Hahnemann S. The Chronic Diseases: Their Peculiar Nature and Their Homoeopathic Cure. New Delhi: B. Jain Publishers (P) Ltd.; 2005. [Google Scholar] [Crossref]

18. Boericke W. Pocket Manual of Homoeopathic Materia Medica and Repertory. 9th ed. New Delhi: B. Jain Publishers (P) Ltd.; 2007. [Google Scholar] [Crossref]

19. Hering C. The Guiding Symptoms of Our Materia Medica. Vol. 1–10. New Delhi: B. Jain Publishers (P) Ltd.; 1993. [Google Scholar] [Crossref]

20. Kent JT. Lectures on Homoeopathic Materia Medica. New Delhi: B. Jain Publishers (P) Ltd.; 2004. [Google Scholar] [Crossref]

21. Hahnemann S. Organon of Medicine. 6th ed. New Delhi: B. Jain Publishers (P) Ltd.; 2002. [Google Scholar] [Crossref]

22. Nash EB. Leaders in Homoeopathic Therapeutics: With Grouping and Classification. 6th ed. New Delhi: B. Jain Publishers (P) Ltd.; 2007. [Google Scholar] [Crossref]

23. Allen HC. Keynotes and Characteristics with Comparisons of Some of the Leading Remedies of the Materia Medica. Reprint ed. New Delhi: B. Jain Publishers (P) Ltd.; 2005. [Google Scholar] [Crossref]

24. Boger CM. A Synoptic Key of the Materia Medica. Reprint ed. New Delhi: B. Jain Publishers (P) Ltd.; 2002. [Google Scholar] [Crossref]

25. Phatak SR. Materia Medica of Homoeopathic Medicines. 2nd reprint ed. New Delhi: B. Jain Publishers (P) Ltd.; 2002. [Google Scholar] [Crossref]

26. Lu X, Li Y, et al. The global and regional burden and trends of migraine from 1990 to 2021: Global Burden of Disease Study 2021. 2025. [Google Scholar] [Crossref]

27. Ernst E. Homeopathic prophylaxis of headaches and migraine? A systematic review. J Pain Symptom Manage. 1999;18(5):353–357. doi:10.1016/S0885-3924(99)00095-0. [Google Scholar] [Crossref]

28. Owen JM, Green BN. Homeopathic treatment of headaches: A systematic review of the literature. J Chiropr Med. 2004;3(2):45–52. doi:10.1016/S0899-3467(07)60085-8. [Google Scholar] [Crossref]

29. Straumsheim P, Borchgrevink C, Mowinckel P, Kierulf H, Hafslund O. Homeopathic treatment of migraine: a double blind, placebo-controlled trial of 68 patients. Br Homoeopath J. 2000;89(1):4–7. doi:10.1054/homp.1999.0332. [Google Scholar] [Crossref]

• Weeping: A Multifaceted Exploration of a Universal Human Expression ‘Unveiling the Historical, Cultural, Physiological, and Psychological Dimensions of a Universal Language’
• The Life and Work of James Tyler Kent: His Contributions to Homoeopathy and the Twelve Observations
• “Corn (Clavus) Treated with Individualized Homoeopathic Medicine: A Case Report”
• “Homeopathic Medicines for Rheumatoid Arthritis and Osteoarthritis: A Systematic Review of Materia Medica Evidence Following PRISMA Guidelines”